[Treatment of chronic non-A, non-B hepatitis with a combination therapy of interferon and an immunopotentiator].
Ooka
T
T
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D001688:Biological Products / Q000008:administration & dosage*; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000473:pathology / Q000628:therapy*; D006525:Hepatitis, Viral, Human / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage*; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000008:administration & dosage*; D010865:Pilot Projects; D011994:Recombinant Proteins
D000276:Adjuvants, Immunologic; D001688:Biological Products; D007370:Interferon Type I; D011994:Recombinant Proteins; D010844:Picibanil